Reaction
Ear Injury reporting signals
As of the last recalculation, Ear Injury appears in 486 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is TOFACITINIB CITRATE (PRR 57.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Tofacitinib Citrate | 17 | 57.5 | 57.6 |
| Emicizumab | 10 | 35.4 | 35.4 |
| Travoprost | 3 | 14.9 | 14.9 |